Joe Bonaccorso's most recent trade in Verrica Pharmaceuticals Inc was a trade of 24,709 Common Stock done at an average price of $2.7 . Disclosure was reported to the exchange on Aug. 26, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.66 per share. | 26 Aug 2024 | 24,709 | 82,107 (0%) | 0% | 2.7 | 65,726 | Common Stock |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.46 per share. | 26 Aug 2024 | 8,993 | 73,114 (0%) | 0% | 2.5 | 22,123 | Common Stock |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 7.06 per share. | 22 Jul 2024 | 25,461 | 106,931 (0%) | 0% | 7.1 | 179,755 | Common Stock |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 22 Jul 2024 | 115 | 106,816 (0%) | 0% | 7.0 | 803 | Common Stock |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) | |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 40,000 | 132,392 (0%) | 0% | 0 | Common Stock | |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.93 per share. | 14 Nov 2023 | 21,580 | 103,658 (0%) | 0% | 2.9 | 63,229 | Common Stock |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.97 per share. | 14 Nov 2023 | 11,266 | 92,392 (0%) | 0% | 3.0 | 33,460 | Common Stock |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2023 | 125,000 | 187,738 (0%) | 0% | 0 | Common Stock | |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2023 | 62,500 | 125,238 (0%) | 0% | 0 | Common Stock | |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 100,000 | 101,000 (0%) | 0% | 0 | Common Stock | |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 4.83 per share. | 21 Jul 2023 | 38,262 | 62,738 (0%) | 0% | 4.8 | 184,805 | Common Stock |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 85,000 | 85,000 | - | - | Employee Stock Option (right to buy) | |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Verrica Pharmaceuticals Inc | Joe Bonaccorso | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 65,000 | 65,000 | - | - | Employee Stock Option (Right to Buy) |